STOCKHOLDERS EQUITY (Details 5) - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Number of Shares, Granted	150,000	590,000
Number of Shares, Exercised	0	0
Number of Shares, Vested and exercisable Ending Balance	7,055,736	7,241,518
Number of Shares, Non-vested Ending Balance	1,205,486	1,118,333
Exercise price	$ 1.24	$ 0.75
Weighted-Average Exercise Price, Exercised	0.00	0.00
Weighted-Average Exercise Price, Non-vested Ending Balance	1.51	1.39
Weighted-Average Grant-Date Fair Value, Granted	0.66	3.15
Weighted-Average Grant-Date Fair Value, Exercised	0.00	0.00
Weighted-Average Grant-Date Fair Value, Vested and exercisable Ending Balance	1.50	1.69
Weighted-Average Grant-Date Fair Value, Non-vested Ending Balance	$ 2.42	$ 2.85
Aggregate Intrinsic Value of Outstanding Warrant Shares, Granted		$ 1,967,500
Aggregate Intrinsic Value of Outstanding Warrant Shares, Vested and exercisable Ending Balance	$ 2,667,549	$ 8,367,683
Options [Member]
Number of Shares, Outstanding Beginning Balance	3,088,333	3,377,222
Number of Shares, Granted	720,169	76,667
Number of Shares, Exercised	0	0
Number of Shares, Expired		(143,333)
Number of Shares, Forfeited		0
Number of Shares, Expired/Forfeited	0	0
Number of Shares, Outstanding Ending Balance	3,808,502	3,310,556
Number of Shares, Vested and exercisable Ending Balance	2,912,778	2,714,893
Number of Shares, Non-vested Ending Balance	895,721	595,663
Weighted-Average Exercise Price, Outstanding Beginning Balance	$ 1.13	$ 1.10
Exercise price	3.46	3.75
Weighted-Average Exercise Price, Exercised	0.00	0.00
Weighted-Average Exercise Price, Forfeited	0.00	0.00
Weighted-Average Exercise Price, Expired	0.00	0.00
Weighted-Average Exercise Price, Outstanding Ending Balance	1.39	1.10
Weighted-Average Exercise Price, Vested and exercisable Ending Balance	0.92	0.80
Weighted-Average Exercise Price, Non-vested Ending Balance	2.91	2.49
Weighted-Average Grant-Date Fair Value, Outstanding Beginning Balance	1.06	1.06
Weighted-Average Grant-Date Fair Value, Granted	1.49	1.61
Weighted-Average Grant-Date Fair Value, Exercised	0.00	0.00
Weighted-Average Grant-Date Fair Value, Forfeited	0.00	0.00
Weighted-Average Grant-Date Fair Value, Expired	0.00	0.00
Weighted-Average Grant-Date Fair Value, Outstanding Ending Balance	1.13	1.01
Weighted-Average Grant-Date Fair Value, Vested and exercisable Ending Balance	1.11	0.89
Weighted-Average Grant-Date Fair Value, Non-vested Ending Balance	$ 1.39	$ 1.82
Aggregate Intrinsic Value of Outstanding Warrant Shares, Outstanding Beginning Balance	$ 1,829,999	$ 2,030,000
Aggregate Intrinsic Value of Outstanding Warrant Shares, Granted	0	0
Aggregate Intrinsic Value of Outstanding Warrant Shares, Exercised	0	0
Aggregate Intrinsic Value of Outstanding Warrant Shares, Forfeited	0	0
Aggregate Intrinsic Value of Outstanding Warrant Shares, Expired	0	0
Aggregate Intrinsic Value of Outstanding Warrant Shares, Outstanding Ending Balance	1,044,134	1,830,000
Aggregate Intrinsic Value of Outstanding Warrant Shares, Vested and exercisable Ending Balance	1,009,056	1,351,901
Aggregate Intrinsic Value of Outstanding Warrant Shares, Non-vested Ending Balance	$ 35,078	$ 478,099
Weighted-Average Remaining Contractual Term (in years), Outstanding Beginning Balance	4 months 24 days	9 months 18 days
Weighted-Average Remaining Contractual Terms (in years), Granted	2 years 9 months 18 days	2 years 9 months 18 days
Weighted-Average Remaining Contractual Term (in years), Outstanding Ending Balance	2 months 12 days	8 months 12 days
Weighted-Average Remaining Contractual Term (in years), Vested and exercisable Ending Balance	3 months 18 days	3 months 18 days
Weighted-Average Remaining Contractual Term (in years), Non-vested Ending Balance	2 years 9 months 18 days	1 year 7 months 6 days